Last updated Nov 15, 2026
A 6-year-old has multiple café-au-lait macules, axillary freckling, and Lisch nodules on slit-lamp exam. His father has similar skin findings and multiple dermal neurofibromas.
AD; NF1 (neurofibromin, a tumor suppressor that holds Ras signaling in check); loss of function, about 50% de novo.
Neurofibromin stimulates the GTPase activity of Ras, which keeps cell proliferation in check; that is why it acts as a tumor suppressor. It also takes part in cell division and in the regulation of adenylyl cyclase and cyclic AMP.
The disorder is loss of function. More than 3000 different variants are known, and most truncate the protein, often by disrupting mRNA splicing. Three points matter in practice:
- Testing: splice variants are 22% to 30% of pathogenic variants, and more than a third of them are missed by genomic DNA sequencing of the coding regions, so methods that add cDNA sequencing detect more.
- Whole-gene deletion (5% to 11%): the 1.4-Mb type 1 deletion brings earlier and more numerous neurofibromas, a higher MPNST risk, more frequent intellectual disability, overgrowth, and coarse facies.
- Variant-specific courses: missense variants at codons 844 to 848 give a severe course with plexiform and spinal neurofibromas, while p.Met992del and missense variants at p.Arg1809 give the pigmentary features without cutaneous neurofibromas.
A variant that arose after conception gives mosaic disease, often localized and milder, yet such a parent can have a child with typical disease, because the child carries the variant in every cell.
Diagnostic criteria (2021 revision; ≥2 required, or ≥1 in a child of an affected parent):
- ≥6 café-au-lait macules (>5mm prepubertal, >15mm postpubertal)
- Axillary or inguinal freckling (Crowe sign)
- ≥2 neurofibromas of any type OR 1 plexiform neurofibroma
- Optic pathway glioma
- ≥2 Lisch nodules (iris hamartomas) on slit-lamp exam OR ≥2 choroidal abnormalities on optical coherence tomography or near-infrared imaging
- A distinctive osseous lesion: sphenoid dysplasia, anterolateral bowing of the tibia, or pseudarthrosis of a long bone
- A heterozygous pathogenic NF1 variant at a variant allele fraction of 50% in apparently normal tissue such as blood
- If only café-au-lait macules and freckling are present, at least one of the two should be bilateral, and Legius syndrome remains possible
Complications:
- Precocious puberty (refer to endocrinology)
- Plexiform neurofibromas → malignant peripheral nerve sheath tumor (MPNST)
- Learning disabilities (~50%)
- Hypertension (renal artery stenosis, pheochromocytoma)
- Primarily a clinical diagnosis: ≥2 of the consensus criteria above (a heterozygous pathogenic NF1 variant now also counts as a criterion)
- Slit-lamp exam for Lisch nodules; brain/orbital MRI when optic pathway glioma is suspected
- Molecular testing of NF1 confirms the diagnosis, aids when criteria are incomplete (young children), and enables prenatal/preimplantation testing
- Legius syndrome (SPRED1) is the main alternative when only café-au-lait macules and freckling are present: about half of people with it meet the 1988 NIH criteria for this disorder, yet it carries none of its tumor risk and needs none of its tumor surveillance. Test NF1 and SPRED1 together in a child with pigmentary findings only.
- Regular ophthalmologic screening in children until age 7 for optic nerve gliomas.
- Breast cancer screening in women (start at age 30 years)
- Surgical removal of painful or bothersome neurofibromas
- Tibial pseudoarthroses may require limb amputation
NF1 is not the only disorder with café-au-lait macules: Legius, McCune-Albright, Noonan, Russell-Silver, and PTEN-hamartoma tumor syndrome can all present with them.